- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 30.58M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 23.66M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 24.08M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $88.79M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $11.5M |
| Capex | Q2 2026 · Mar 31, 2026 | $722K |
| Capex | Q2 2026 · Mar 31, 2025 | $972K |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $24.15M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$15.63M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $81M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $0 |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $7.14M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $66.67M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $317.38M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $389.58M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $58.57M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $70.69M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $198.18M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $120.69M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $78.21M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $137.63M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $636.42M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $638.41M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $0.08 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.08 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.07 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $0.09 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.08 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $29.06M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $56.05M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $26.28M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $52.76M |
| Net Income | Q2 2026 · Mar 31, 2026 | $1.46M |
| Net Income | Q2 2026 · Mar 31, 2026 | $1.95M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$154K |
| Net Income | Q2 2026 · Mar 31, 2025 | $1.9M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $3.74M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $5.35M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $5.06M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $7.11M |
| Revenue | Q2 2026 · Mar 31, 2026 | $57.52M |
| Revenue | Q2 2026 · Mar 31, 2026 | $110.19M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $54.14M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $106.36M |